X0306 4 2021-03-08 0 0001434316 FATE THERAPEUTICS INC FATE 0001586892 Shoemaker Daniel D C/O FATE THERAPEUTICS, INC.; 3535 GENERAL ATOMICS COURT #200 SAN DIEGO CA 92121 0 1 0 0 Chief Scientific Officer Common stock 2021-03-08 4 S 0 3298 78.6039 D 94722 D Common stock 2021-03-08 4 S 0 4627 79.5841 D 90095 D Common stock 2021-03-08 4 S 0 5174 80.7349 D 84921 D Common stock 2021-03-08 4 S 0 2993 81.5985 D 81928 D Common stock 2021-03-08 4 S 0 2480 83.4635 D 79448 D Common stock 2021-03-08 4 S 0 2728 84.2026 D 76720 D Common stock 2021-03-08 4 S 0 2900 85.5021 D 73820 D Common stock 2021-03-08 4 S 0 800 86.70 D 73020 D This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2020. Represents the weighted average sale price of the shares sold ranging from $78.08 to $79.02 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price. Represents the weighted average sale price of the shares sold ranging from $79.09 to $80.08 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price. Represents the weighted average sale price of the shares sold ranging from $80.12 to $81.09 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price. Represents the weighted average sale price of the shares sold ranging from $81.19 to $82.15 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price. Represents the weighted average sale price of the shares sold ranging from $82.74 to $83.68 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price. Represents the weighted average sale price of the shares sold ranging from $83.775 to $84.76 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price. Represents the weighted average sale price of the shares sold ranging from $84.99 to $85.81 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price. /s/ Cindy R. Tahl, as Attorney-in-Fact 2021-03-09